TY - JOUR
T1 - Trends in Cancer Incidence in US Adolescents and Young Adults, 1973-2015
AU - Scott, Alyssa R.
AU - Stoltzfus, Kelsey C.
AU - Tchelebi, Leila T.
AU - Trifiletti, Daniel M.
AU - Lehrer, Eric J.
AU - Rao, Pooja
AU - Bleyer, Archie
AU - Zaorsky, Nicholas G.
N1 - Publisher Copyright:
© 2020 American Medical Association. All rights reserved.
PY - 2020/12/1
Y1 - 2020/12/1
N2 - Importance: Previous studies have demonstrated that adolescents and young adults (AYAs) with cancer are a distinct cancer population; however, research on long-term epidemiological trends and characteristics of cancers in AYAs is lacking. Objective: To characterize the epidemiology of cancer in AYAs aged 15 to 39 years with respect to (1) patient demographic characteristics, (2) frequencies of cancer types, and (3) cancer incidence trends over time. Design, Setting, and Participants: This retrospective, serial cross-sectional, population-based study used registry data from the Surveillance, Epidemiology, and End Results (SEER) database from January 1, 1973, to December 31, 2015 (SEER 9 and SEER 18). The study population was from geographically distinct US regions, chosen to represent the racial and ethnic heterogeneity of the country. Initial analyses were performed from January 1 to August 31, 2019. Main Outcomes and Measures: Incidence rates and descriptive epidemiological statistics for patients aged 15 to 39 years with invasive cancer. Results: A total of 497452 AYAs diagnosed from 1973 to 2015 were included in this study, with 293848 (59.1%) female and 397295 (79.9%) White participants. As AYAs aged, an increase in the relative incidence of carcinomas and decrease in the relative incidence of leukemias, lymphomas, germ cell and trophoblastic neoplasms, and neoplasms of the central nervous system occurred. Among the female AYAs, 72564 (24.7%) were diagnosed with breast carcinoma; 48865 (16.6%), thyroid carcinoma; and 33828 (11.5%), cervix and uterus carcinoma. Among the male AYAs, 37597 (18.5%) were diagnosed with testicular cancer; 20850 (10.2%), melanoma; and 19532 (9.6%), non-Hodgkin lymphoma. The rate of cancer in AYAs increased by 29.6% from 1973 to 2015, with a mean annual percentage change (APC) per 100000 persons of 0.537 (95% CI, 0.426-0.648; P <.001). Kidney carcinoma increased at the greatest rate for both male (APC, 3.572; 95% CI, 3.049-4.097; P <.001) and female (APC, 3.632; 95% CI, 3.105-4.162; P <.001) AYAs. Conclusions and Relevance: In this cross-sectional, US population-based study, cancer in AYAs was shown to have a unique epidemiological pattern and is a growing health concern, with many cancer subtypes having increased in incidence from 1973 to 2015. Continued research on AYA cancers is important to understanding and addressing the distinct health concerns of this population.
AB - Importance: Previous studies have demonstrated that adolescents and young adults (AYAs) with cancer are a distinct cancer population; however, research on long-term epidemiological trends and characteristics of cancers in AYAs is lacking. Objective: To characterize the epidemiology of cancer in AYAs aged 15 to 39 years with respect to (1) patient demographic characteristics, (2) frequencies of cancer types, and (3) cancer incidence trends over time. Design, Setting, and Participants: This retrospective, serial cross-sectional, population-based study used registry data from the Surveillance, Epidemiology, and End Results (SEER) database from January 1, 1973, to December 31, 2015 (SEER 9 and SEER 18). The study population was from geographically distinct US regions, chosen to represent the racial and ethnic heterogeneity of the country. Initial analyses were performed from January 1 to August 31, 2019. Main Outcomes and Measures: Incidence rates and descriptive epidemiological statistics for patients aged 15 to 39 years with invasive cancer. Results: A total of 497452 AYAs diagnosed from 1973 to 2015 were included in this study, with 293848 (59.1%) female and 397295 (79.9%) White participants. As AYAs aged, an increase in the relative incidence of carcinomas and decrease in the relative incidence of leukemias, lymphomas, germ cell and trophoblastic neoplasms, and neoplasms of the central nervous system occurred. Among the female AYAs, 72564 (24.7%) were diagnosed with breast carcinoma; 48865 (16.6%), thyroid carcinoma; and 33828 (11.5%), cervix and uterus carcinoma. Among the male AYAs, 37597 (18.5%) were diagnosed with testicular cancer; 20850 (10.2%), melanoma; and 19532 (9.6%), non-Hodgkin lymphoma. The rate of cancer in AYAs increased by 29.6% from 1973 to 2015, with a mean annual percentage change (APC) per 100000 persons of 0.537 (95% CI, 0.426-0.648; P <.001). Kidney carcinoma increased at the greatest rate for both male (APC, 3.572; 95% CI, 3.049-4.097; P <.001) and female (APC, 3.632; 95% CI, 3.105-4.162; P <.001) AYAs. Conclusions and Relevance: In this cross-sectional, US population-based study, cancer in AYAs was shown to have a unique epidemiological pattern and is a growing health concern, with many cancer subtypes having increased in incidence from 1973 to 2015. Continued research on AYA cancers is important to understanding and addressing the distinct health concerns of this population.
UR - http://www.scopus.com/inward/record.url?scp=85097036222&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85097036222&partnerID=8YFLogxK
U2 - 10.1001/jamanetworkopen.2020.27738
DO - 10.1001/jamanetworkopen.2020.27738
M3 - Article
C2 - 33258907
AN - SCOPUS:85097036222
SN - 2574-3805
VL - 3
SP - E2027738
JO - JAMA network open
JF - JAMA network open
IS - 12
ER -